Atlas Trials

COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies

Clinical trial NCT05028374 · COMPLETED

Trial details

NCT number
NCT05028374
Sponsor
Barbara Ann Karmanos Cancer Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple MyelomaAL AmyloidosisChronic Lymphocytic Leukemia
Start date
2021-08-17
Primary completion
2021-11-02
Enrollment
119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.